Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationHuman molecular genetics
View this publicationEBioMedicine
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationNeurochemical research
View this publicationThe World Allergy Organization journal
View this publicationImmunology letters
View this publicationScientific reports
View this publicationFrontiers in immunology
View this publicationSTAR protocols
View this publication